Janet Linn Elected Vice Chair of Food, Drug and Cosmetic Law Section of NYSBA

February 2017

Bleakley Platt Partner Janet Linn has been elected to the position of Vice Chair of the Food, Drug and Cosmetic Section of the New York State Bar Association.

Ms. Linn has served as a member of the Executive Committee for the Section for several years and is looking forward to increasing her involvement. She recently spoke as part of the Drug Committee panel of the Food, Drug and Cosmetic Section at the NYSBA Annual Meeting, with a presentation titled “Evolving Requirements for NCE [New Chemical Entity] Exclusivity.” The presentation discussed recent court and FDA decisions affording pharmaceutical companies longer periods of exclusivity precluding generic competition and concomitant delays of Hatch-Waxman challenges by generic companies.

As Vice Chair, Ms. Linn will assist the Section chair in arranging CLEs and other events of interest to practitioners in the area and with submission of commentary by the Section on relevant proposed federal and state legislation.

Last November, Ms. Linn co-moderated a CLE program “REMS and Other Drug Distribution Restrictions” presented by the Food, Drug and Cosmetic and the Antitrust Sections of the New York State Bar Association.

Ms. Linn, a Partner in the firm’s Intellectual Property Litigation practice group, focuses her practice on patent, trademark and trade secret litigation and counseling. She has extensive trial and litigation experience in a broad range of technologies, including pharmaceuticals, medical devices, consumer products, and mechanical devices. Ms. Linn also has substantial experience in trademark prosecution and inter partes proceedings, as well as unfair competition, false advertising, and copyright litigation. She has particular expertise in pharmaceutical (Hatch-Waxman) patent litigation, and has acted as trial counsel in patent, trade secret and antitrust actions involving pharmaceuticals with annual billion dollar sales.

Read her complete profile here.